Skip to content

Maternal Experience in painless delivery using En2nox

Maternal Experience of En2nox Painless Delivery: A phenomenology Research in Iran, 2009

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138901183525N1
Enrollment
30
Registered
2010-04-07
Start date
2009-04-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia during labor and delivery. Other complications of anaesthesia during labour and delivery

Interventions

Dosage of En2nox: 50% nitro, 50% oxygen, Duration of treatment: from beginning of the active phase until the end of second delivery, Method: using mask by mother, 30 second before beginning until the
Treatment - Drugs

Sponsors

Islamic Azad University of Toyserkan
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Normal vaginal delivery, presence of labor pain, candidate for use of En2nox, Exclusion criteria: Head injury with unconsciousness, pneumothorax, facial trauma, atherosclerosis, facial nerve injury

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Maternal expriences. Timepoint: 24 hours after delivery. Method of measurement: Deep interview.

Secondary

MeasureTime frame
Negative and positive outcome. Timepoint: 24 hours after delivery. Method of measurement: Deep interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Asle Toghiri

Islamic Azad University of Toyserkan

toyserkan_iau@yahoo.com+98 85 2422 3288

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026